Lifevantage Other Current Assets vs Non Current Liabilities Total Analysis
LFVN Stock | USD 13.75 0.08 0.58% |
Lifevantage financial indicator trend analysis is infinitely more than just investigating Lifevantage recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lifevantage is a good investment. Please check the relationship between Lifevantage Other Current Assets and its Non Current Liabilities Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.
Other Current Assets vs Non Current Liabilities Total
Other Current Assets vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lifevantage Other Current Assets account and Non Current Liabilities Total. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Lifevantage's Other Current Assets and Non Current Liabilities Total is 0.12. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Lifevantage, assuming nothing else is changed. The correlation between historical values of Lifevantage's Other Current Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Lifevantage are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Other Current Assets i.e., Lifevantage's Other Current Assets and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.12 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Non Current Liabilities Total
Most indicators from Lifevantage's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lifevantage current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.At this time, Lifevantage's Tax Provision is very stable compared to the past year. As of the 27th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.62, while Selling General Administrative is likely to drop about 34.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 168.3M | 170.0M | 158.7M | 112.6M | Total Revenue | 206.4M | 213.4M | 200.2M | 136.0M |
Lifevantage fundamental ratios Correlations
Click cells to compare fundamentals
Lifevantage Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lifevantage fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 58.9M | 78.7M | 70.7M | 66.1M | 60.3M | 30.9M | |
Short Long Term Debt Total | 1.2M | 18.2M | 15.8M | 13.1M | 13.6M | 7.0M | |
Other Current Liab | 19.5M | 13.0M | 12.5M | 10.5M | 9.5M | 10.0M | |
Total Current Liabilities | 25.0M | 25.2M | 25.7M | 19.6M | 22.3M | 13.6M | |
Total Stockholder Equity | 33.3M | 36.8M | 31.5M | 34.6M | 26.0M | 27.3M | |
Net Debt | (21.0M) | (5.0M) | (4.4M) | (8.5M) | (3.3M) | (3.4M) | |
Accounts Payable | 3.5M | 6.7M | 7.5M | 3.5M | 5.9M | 6.1M | |
Cash | 22.1M | 23.2M | 20.2M | 21.6M | 16.9M | 10.5M | |
Cash And Short Term Investments | 22.1M | 23.2M | 20.2M | 21.6M | 16.9M | 10.7M | |
Net Receivables | 2.6M | 4.0M | 5.1M | 1.9M | 3.3M | 2.2M | |
Common Stock Shares Outstanding | 14.6M | 14.3M | 13.1M | 12.6M | 13.0M | 8.9M | |
Liabilities And Stockholders Equity | 58.9M | 78.7M | 70.7M | 66.1M | 60.3M | 30.9M | |
Non Current Liabilities Total | 604K | 16.7M | 13.5M | 11.9M | 12.0M | 8.7M | |
Other Stockholder Equity | 126.4M | 129.0M | 131.1M | 134.3M | 136.6M | 69.8M | |
Total Liab | 25.6M | 41.9M | 39.2M | 31.5M | 34.3M | 20.3M | |
Total Current Assets | 43.9M | 48.1M | 47.0M | 44.3M | 37.6M | 22.3M | |
Short Term Debt | 1.2M | 4.3M | 5.2M | 3.0M | 3.6M | 3.4M | |
Retained Earnings | (93.3M) | (92.3M) | (98.4M) | (98.3M) | (108.7M) | (103.3M) | |
Non Current Assets Total | 15.0M | 30.7M | 23.7M | 21.8M | 22.7M | 23.8M | |
Non Currrent Assets Other | 1.7M | 1.7M | 1.3M | 569K | 680K | 950.6K | |
Other Current Assets | 5.2M | 4.8M | 5.2M | 4.8M | 2.4M | 3.2M | |
Accumulated Other Comprehensive Income | 144K | 104K | (1.1M) | (1.4M) | (1.9M) | (1.8M) | |
Property Plant And Equipment Net | 8.1M | 24.8M | 20.5M | 17.8M | 17.4M | 18.3M | |
Inventory | 13.9M | 16.1M | 16.5M | 16.1M | 15.1M | 10.5M | |
Property Plant And Equipment Gross | 8.1M | 24.8M | 20.5M | 17.8M | 31.9M | 33.5M | |
Intangible Assets | 851K | 719K | 587K | 455K | 323K | 306.9K | |
Current Deferred Revenue | 792K | 319K | 78K | 834K | 860K | 872.9K | |
Other Liab | 604K | 694K | 308K | 299K | 269.1K | 255.6K | |
Other Assets | 3.8M | 2.9M | 2.6M | 3.6M | 4.1M | 3.2M | |
Property Plant Equipment | 8.1M | 24.8M | 20.5M | 9.1M | 10.4M | 8.1M | |
Net Tangible Assets | 32.4M | 36.1M | 30.9M | 34.2M | 39.3M | 24.3M | |
Retained Earnings Total Equity | (100.0M) | (93.3M) | (92.3M) | (98.3M) | (88.5M) | (92.9M) | |
Capital Surpluse | 127.1M | 126.4M | 129.0M | 134.3M | 154.5M | 133.1M | |
Non Current Liabilities Other | 604K | 694K | 308K | 11.9M | 198K | 188.1K |
Pair Trading with Lifevantage
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifevantage position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifevantage will appreciate offsetting losses from the drop in the long position's value.Moving against Lifevantage Stock
0.88 | CL | Colgate Palmolive Fiscal Year End 24th of January 2025 | PairCorr |
0.76 | UL | Unilever PLC ADR | PairCorr |
0.74 | EPC | Edgewell Personal Care | PairCorr |
0.74 | KMB | Kimberly Clark Fiscal Year End 22nd of January 2025 | PairCorr |
0.65 | NUS | Nu Skin Enterprises | PairCorr |
The ability to find closely correlated positions to Lifevantage could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifevantage when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifevantage - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifevantage to buy it.
The correlation of Lifevantage is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifevantage moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifevantage moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifevantage can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifevantage. If investors know Lifevantage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifevantage listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.8 | Dividend Share 0.15 | Earnings Share 0.32 | Revenue Per Share 15.853 | Quarterly Revenue Growth (0.08) |
The market value of Lifevantage is measured differently than its book value, which is the value of Lifevantage that is recorded on the company's balance sheet. Investors also form their own opinion of Lifevantage's value that differs from its market value or its book value, called intrinsic value, which is Lifevantage's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifevantage's market value can be influenced by many factors that don't directly affect Lifevantage's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifevantage's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifevantage is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifevantage's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.